Search filters

List of works by Elvira Favoino

Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma

scientific article published on 15 July 2016

Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin

scientific article published on 8 October 2015

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma

scientific article published on 05 February 2016

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis

scientific article

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

scientific article

CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases

scientific article published in June 2005

CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases

scientific article

CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading

scientific article published in 2019

CD20: a target antigen for immunotherapy of autoimmune diseases

scientific article

Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis

scientific article published on 09 July 2013

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis

scientific article published on 10 May 2015

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice

article

Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4

scientific article

Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor

scientific article published on 13 October 2005

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma.

scientific article published on 15 January 2015

Harnessing host innate immunity may combat acquired resistance to BRAFi

scientific article published on 6 May 2014

Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope

scientific article published on 01 September 2004

Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy

scientific article

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

article

Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders

scientific article published on 6 February 2018

Raynaud's phenomenon: from molecular pathogenesis to therapy

scientific article published on 10 January 2014

Rheumatic disorders as paraneoplastic syndromes

scientific article published on 22 February 2008

Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count

scientific article

Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease

scientific article

The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells

scientific article published on August 2011

Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes

scientific article

Paulina is supported by:

About Paulina

Help